Preventive drugs for Huntington’s disease: A choice-based conjoint survey of patient preferences

INTRODUCTION: This research examined the perspective of the Huntington’s disease (HD) community regarding the use of predictive biomarkers as endpoints for regulatory approval of therapeutics to prevent or delay the onset of clinical HD in asymptomatic mutation carriers. METHODS: An online, choice-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Parrish, Marcus C., Hanson-Kahn, Andrea, Srinivasan, V., Grimes, Kevin V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003635/
https://www.ncbi.nlm.nih.gov/pubmed/35433035
http://dx.doi.org/10.1017/cts.2022.372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003635/
https://www.ncbi.nlm.nih.gov/pubmed/35433035
http://dx.doi.org/10.1017/cts.2022.372

Ejemplares similares